Selena

Selena Therapeutics is a biotechnology company based in Basel, Switzerland, focused on the discovery and development of small molecule drugs that target RNA. By leveraging a proprietary platform that integrates structural biology, computational chemistry, and RNA biochemistry, the company aims to modulate RNA function to treat diseases with high unmet medical needs. Their approach focuses on identifying druggable pockets within complex RNA structures, enabling the development of oral therapies for targets previously considered undruggable. Selena's primary therapeutic focus includes oncology and rare genetic disorders, where RNA-mediated pathways play a critical role in disease progression.